CARR vs RLAY · P/E 43, rev $21.75B vs rev $3.4M
Carrier Global Corp (CARR) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the CARR and RLAY stock pages for the full models.
Not investment advice.